NDV-HXP-S-KP.2, COVID-19 mRNA Vaccine — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-19 in 2mo
ESTIMATED |
READOUT
Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vacc
Phase 2 · COVID-19 |
CastleVax Inc. | NDV-HXP-S-KP.2, COVID-19 mRNA Vaccine |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|